New England Journal of Medicine 2014-10-02

Exemestane with ovarian suppression in premenopausal breast cancer.

Vito Amoroso, Alfredo Berruti, Edda Simoncini

Index: N. Engl. J. Med. 371(14) , 1357, (2014)

Full Text: HTML

Abstract


Related Compounds

Related Articles:

TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

2015-01-02

[Oncogene 34(1) , 27-38, (2015)]

Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.

2015-01-01

[Carcinogenesis 36(1) , 122-32, (2015)]

Exposure to the polyester PET precursor--terephthalic acid induces and perpetuates DNA damage-harboring non-malignant human breast cells.

2015-01-01

[Carcinogenesis 36(1) , 168-76, (2015)]

Chronic centrosome amplification without tumorigenesis.

2015-11-17

[Proc. Natl. Acad. Sci. U. S. A. 112 , E6321-30, (2015)]

Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats.

2014-12-01

[Toxicol. Pathol. 42(8) , 1188-96, (2014)]

More Articles...